Singapore Biotech Brings New Cancer Drug to First Patient

After years of development in Singapore, a groundbreaking cancer treatment reached its first human patient in London, targeting a protein that's stumped scientists for three decades.

Hummingbird Bioscience's HMBD-001 could change how we fight stubborn tumors.